Palmoplantar Pustulosis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Palmoplantar Pustulosis – Drugs In Development, 2024 report and make more profitable business decisions.
Palmoplantar pustulosis (PPP) is a recurrent inflammatory disease that affects the palms and soles. It causes crops of sterile pustules that are usually treatment resistant. Itching, pain, and burning sensation may be present. The possible causative agents of PPP are smoking, infections, contact allergies, and biological therapies like TNF alpha inhibitors. Skin biopsy and culture tests can be helpful in diagnosing the PPP. Treatment options include use of emollients (like salicylic acid ointment, urea cream, etc.), topical steroids, coal tar, acitretin, and phototherapy. Colchicine, dapsone, methotrexate, tetracycline antibiotics, and ciclosporin can also be used. Other measures like quitting smoking, wearing comfortable footwear, and avoiding friction and minor injuries can be helpful.
The Palmoplantar Pustulosis drugs in development market research report provide comprehensive information on the therapeutics under development for Palmoplantar Pustulosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Palmoplantar Pustulosis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Palmoplantar Pustulosis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 3 molecules, with 3 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Palmoplantar Pustulosis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Palmoplantar Pustulosis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Palmoplantar Pustulosis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Pharmaceuticals reports